The Bioenhancement division has reached the Phase II milestone on the HECATE platform integration. Neural synchronization indices have improved across all trial cohorts, and the expanded calibration protocol is now in use at the Sedona facility. Lance Hunter and the team will present findings at the quarterly review. Project documentation is available through the research portal. For data access requests, contact lhunter. The next phase will focus on scalability testing and extended-duration trials.